Pharvaris (PHVS) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Powered by 
Analysis
Pharvaris (PHVS) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -99.85% |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | -5.07% |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 1.70% |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 10.87% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 19.14% |
| 10 | Pharvaris | 2.14 Bn | 1.77 Bn | 85,072.10 | 77,838,523.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77,838,523.85% |
| Mar 31, 2026 | 91,233,200.72% |
| Dec 31, 2025 | 104,925,855.90% |
| Sep 30, 2025 | 35.23% |
| Jun 30, 2025 | 192.71% |
| Mar 31, 2025 | 219.92% |
| Dec 31, 2024 | 196.16% |
| Sep 30, 2024 | 158.58% |
| Jun 30, 2024 | -100.00% |
| Mar 31, 2024 | 20.65% |
| Dec 31, 2023 | 21.92% |
| Sep 30, 2023 | 25.73% |
| Jun 30, 2023 | 158,375,457.61% |
| Mar 31, 2023 | 50.11% |
| Dec 31, 2022 | 59.62% |
| Sep 30, 2022 | 59.08% |
| Jun 30, 2022 | 67.45% |
| Mar 31, 2022 | 112.76% |
| Dec 31, 2021 | 113.84% |
| Dec 31, 2020 | 304.16% |